Name: SOPHIA GENETICS SA (SOPH) Stock
Brand: SOPHIA GENETICS SA
Rating: 5.5 (3 reviews)

SOPH Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Sophia Genetics

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

9 days ago - By: Zacks Investment Research - Mentions: TXG TEM

Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?

12 days ago - By: Sophia Genetics

A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben

12 days ago - By: Sophia Genetics

A.D.A.M. Innovations et SOPHiA GENETICS s'associent pour faire progresser les tests de biopsie liquide et les diagnostics compagnons pour l'oncologie de précision au Japon

12 days ago - By: Sophia Genetics

A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

6 months ago - By: Benzinga - Mentions: ENLT SSL ATKR GPOR ...

Earnings Scheduled For May 6, 2025

13 days ago - By: Sophia Genetics

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

13 days ago - By: Sophia Genetics

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

a month ago - By: Sophia Genetics - Mentions: MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

a month ago - By: Myriad Genetics, Inc. - Mentions: MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

a month ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

2 months ago - By: Sophia Genetics

SOPHiA GENETICS en Jessa Ziekenhuis kondigen samenwerking aan op het gebied van precisieoncologie tijdens het European Congress of Pathology

2 months ago - By: Sophia Genetics

SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie

2 months ago - By: Sophia Genetics

SOPHiA GENETICS et Jessa Ziekenhuis annoncent un partenariat en oncologie de précision au Congrès européen de pathologie

2 months ago - By: Sophia Genetics

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

2 months ago - By: Zacks Investment Research - Mentions: AZN ABBV TEM

Strategic Partnerships Power Tempus AI's Healthcare Expansion

3 months ago - By: Zacks Investment Research - Mentions: IRTC TEM

Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?

3 months ago - By: Sophia Genetics

SOPHiA GENETICS Reports Second Quarter 2025 Results

3 months ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

6 months ago - By: Zacks Investment Research - Mentions: AZN IRTC TEM

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

6 months ago - By: Zacks Investment Research - Mentions: CTEV

SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Sophia Genetics

SOPHiA GENETICS Reports First Quarter 2025 Results

6 months ago - By: Zacks Investment Research - Mentions: TXG TEM

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

6 months ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

6 months ago - By: Zacks Investment Research - Mentions: AZN IRTC TEM

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS

6 months ago - By: Zacks Investment Research - Mentions: AZN IRTC TEM

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

6 months ago - By: Sophia Genetics

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

7 months ago - By: Precision for Medicine

Precision for Medicine s'associe à SOPHiA GENETICS pour étendre ses services biopharmaceutiques avec la plateforme SOPHiA DDM™ et ses capacités de biopsie liquide

7 months ago - By: Precision for Medicine

Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM™-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern

7 months ago - By: Precision for Medicine

SOPHIA GENETICS SA (SOPH) Stock News

SOPH Latest News, Press Relases and Analysis

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?

A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben

A.D.A.M. Innovations et SOPHiA GENETICS s'associent pour faire progresser les tests de biopsie liquide et les diagnostics compagnons pour l'oncologie de précision au Japon

A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan

Earnings Scheduled For August 5, 2025

Earnings Scheduled For May 6, 2025

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

SOPHiA GENETICS en Jessa Ziekenhuis kondigen samenwerking aan op het gebied van precisieoncologie tijdens het European Congress of Pathology

SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie

SOPHiA GENETICS et Jessa Ziekenhuis annoncent un partenariat en oncologie de précision au Congrès européen de pathologie

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

Strategic Partnerships Power Tempus AI's Healthcare Expansion

Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?

SOPHiA GENETICS Reports Second Quarter 2025 Results

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates

SOPHiA GENETICS Reports First Quarter 2025 Results

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Precision for Medicine s'associe à SOPHiA GENETICS pour étendre ses services biopharmaceutiques avec la plateforme SOPHiA DDM™ et ses capacités de biopsie liquide

Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM™-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern

Precision for Medicine se asocia con SOPHiA GENETICS para ampliar los servicios biofarmacéuticos